Literature DB >> 12738401

Evaluation of cystatin C and beta-2 microglobulin as markers of renal function in patients with type 2 diabetes mellitus.

Olusegun A Mojiminiyi1, Nabila Abdella.   

Abstract

BACKGROUND: Despite recent studies showing that serum cystatin C (CC) is a better marker for GFR than the ubiquitously used serum creatinine, its clinical utility remains under evaluation.
METHODS: To evaluate their usefulness in patients with type 2 diabetes mellitus (DM), serum concentrations of CC, beta-2 microglobulin (B2M) and creatinine were measured in 105 (38 males, 67 females) Kuwaiti patients with type 2 DM. The results were compared with creatinine clearance (Ccr), which was measured (mCcr) and estimated (eCcr) with the Cockroft-Gault formula, and correlated with 24-h urine protein and early morning urine albumin/creatinine excretion ratio.
RESULTS: In patients with eCcr and mCcr results (n=51), eCcr and mCcr showed significant correlation with each other (r's=.86, P<.0001) with no significant difference between the two. In all patients (n=105), CC and B2M showed significant correlation with each other (r's=.82, P<.0001) and with serum creatinine concentration (r's=.77 and.84, respectively, P<.0001). Serum CC, B2M and creatinine showed significant (P<.001) inverse correlation with eCcr (r's=-.63, -.61 and -.76, respectively). Partial correlations after correcting for age and sex improved the correlation of serum creatinine with eCcr (r=-.81, P<.0001), but there was no significant change in the correlations of CC and B2M with eCcr (r=-.65, P<.0001 and r=-.62, P<.0001, respectively). Receiver operating characteristic (ROC) plots for serum CC, B2M and creatinine for detection of changes in the eCcr showed that the area under the ROC curve+/-S.E. is 0.897+/-0.119 for CC, 0.871+/-0.091 for B2M and 0.785+/-0.087 for serum creatinine. There was no statistically significant difference between the areas under the curve (AUC) for serum creatinine and CC (P=.07) and B2M (P=.12). CC had the highest sensitivity for detection of eCcr (<60 ml/min/1.73 m(2)) at routinely used cutoff values. CC was also the best discriminator when patients with normoalbuminuria were compared with patients with microalbuminuria.
CONCLUSION: Although there is no significant difference in the overall diagnostic accuracies of CC, B2M and creatinine for the detection of changes in the GFR, CC is the most sensitive marker at routinely used cutoff values and would be more clinically useful than B2M or serum creatinine in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738401     DOI: 10.1016/s1056-8727(02)00177-0

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  10 in total

1.  Comparison of renal function markers in Kuwaiti patients with sickle cell disease.

Authors:  R Marouf; O Mojiminiyi; N Abdella; M Kortom; H Al Wazzan
Journal:  J Clin Pathol       Date:  2006-04       Impact factor: 3.411

2.  Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation.

Authors:  Hideharu Muto; Kazuteru Ohashi; Minoru Ando; Hideki Akiyama; Hisashi Sakamaki
Journal:  Int J Hematol       Date:  2010-03-03       Impact factor: 2.490

3.  Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy.

Authors:  Anne Julie Overgaard; Henning Gram Hansen; Maria Lajer; Lykke Pedersen; Lise Tarnow; Peter Rossing; James N McGuire; Flemming Pociot
Journal:  Proteome Sci       Date:  2010-02-03       Impact factor: 2.480

4.  Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules.

Authors:  Joon-Sung Park; Gheun-Ho Kim; Chong Myung Kang; Chang Hwa Lee
Journal:  Korean J Intern Med       Date:  2010-02-26       Impact factor: 3.165

5.  Plasma biomarkers improve prediction of diabetic kidney disease in adults with type 1 diabetes over a 12-year follow-up: CACTI study.

Authors:  Petter Bjornstad; Laura Pyle; David Z I Cherney; Richard J Johnson; Rachel Sippl; Randy Wong; Marian Rewers; Janet K Snell-Bergeon
Journal:  Nephrol Dial Transplant       Date:  2018-07-01       Impact factor: 5.992

6.  A Study on the Relationship between Serum Beta 2-Microglobulin Levels, Underlying Chronic Kidney Disease, and Peripheral Arterial Disease in High-Vascular-Risk Patients.

Authors:  Diego Real de Asúa; Ramón Puchades; Iluminada García-Polo; Carmen Suárez
Journal:  Int Cardiovasc Res J       Date:  2012-12-15

7.  Interrelationship of βeta-2 microglobulin, blood urea nitrogen and creatinine in streptozotocin-induced diabetes mellitus in rabbits.

Authors:  Shahram Javadi; Siamak Asri-Rezaei; Maryam Allahverdizadeh
Journal:  Vet Res Forum       Date:  2014       Impact factor: 1.054

8.  Cystatin C as a surrogate for glomerular filtration rate in the presence of proteinuria.

Authors:  Thomas Ledson; Matthew L P Howse; Norman B Roberts; Graham J Kemp; Peter S Williams
Journal:  NDT Plus       Date:  2008-06

9.  Cystatin C, Vitamin D and Thyroid Function Test Profile in Chronic Kidney Disease Patients.

Authors:  Marlene Tapper; Donovan A McGrowder; Lowell Dilworth; Adedamola Soyibo
Journal:  Diseases       Date:  2021-01-03

10.  Comparison of serum cystatin C and creatinine as a marker for early detection of decreasing glomerular filtration rate in renal transplants.

Authors:  Young Jae Jung; Hyang Ran Lee; Oh Jung Kwon
Journal:  J Korean Surg Soc       Date:  2012-07-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.